The US FDA says that Bioidenticals are a “Public Health Concern”.
A ban on BHRT is likely.
From an article in the “Green Medicine” Magazine by Jonathan V. Wright M.D. | Mar 7, 2022 |
GM Articles, and Susan Merenstein. [1]
THAT’S TERRIBLE FOR WOMEN IN THE USA,
BUT WHAT ABOUT WOMEN IN CANADA ?
The US FDA has announced [2] that, based on a study which they commissioned, [3] the use of compounded BHT is a public health concern: a ban on BHRT is likely.
The FDA will likely move quickly to ban these critical medicines, starting with Estriol, which by volume, forms 80% of BIEST (BIEST cures Hot Flashes, protects women from osteoporosis, reduces the probability of breast cancer, prevents postmenopausal deterioration of the female organs and helps to prevent urine loss).
The idea that BHRT is a public health “concern” has no factual basis. [4]
(1) A review [2] of the clinical literature concluded that bioidentical hormones pose lower risks, including the risk of breast cancer and cardiovascular disease, than “big pharma” can provide. This is true, if only because compounded BHRT allows tailoring of the dose to fit the needs of the individual woman.
(2) The review concluded that compounded HRT creams [2] are more effective than synthetic or animal-derived hormones.
(3) Members of the NASEM committee, the FDA’s study group, acknowledged [3] that women prefer Compounded BHT, but said that women’s preference is not enough to justify its use.
(4) The result will be that US women may not be able to obtain Estriol, which is included in the BIEST formulation because it protects against breast cancer.
WHAT THE FDA SAYS, IN EFFECT, IS:
“We know better than women and their doctors”.
As Dr. Wright says,
- The grassroots must mobilize, in the interest of their health and wellbeing.
We need to put forward a strong response to this threat. - What seems to be underway is an attempt to create drug company monopolies: this cannot be allowed to stand.
This is one more case of “the system” favouring the bottom line of big drug companies, over the welfare of the people, women in particular.
MESSAGE {from Dr. Wright):
- We need to collect as many positive stories about cBHRT as possible before the FDA decides to ban these crucial hormones and our quality of life!
VISIT HERE TO TAKE ACTION: https://secure3.convio.net/aahf/site/Advocacy?cmd=display&page=UserAction&id=3579 - Also, please give your testimonial right away at https://compounding.com/mystory!
MESSAGE (from Dr. Harry):
This is “the thin edge of the wedge” [5]. A successful ban on Estriol will, inescapably, be followed by further inroads on the practice of compounding pharmacy.
The eventual result will be the outlawing of compounding,
so that all medications and supplements can be supplied
by big pharmaceutical companies in the USA.
BUT THERE IS AN IMPORTANT CAVEAT:
WHAT ABOUT CANADIAN WOMEN?
SHOULD WE DO NOTHING, JUST WAIT UNTIL IT HITS US, TOO ?
REFERENCES
[3] https://www.nationalacademies.org/our-work/clinical-utility-of-treating-patients-with-compounded-bioidentical-hormone-replacement-therapy
[4] https://www.researchgate.net/publication/23959867_The_Bioidentical_Hormone_Debate_Are_Bioidentical_Hormones_Estradiol_Estriol_and_Progesterone_Safer_or_More_Efficacious_than_Commonly_Used_Synthetic_Versions_in_Hormone_Replacement_Therapy
[5] https://anh-usa.org/fda-rigs-process-against-estriol-other-bioidenticals/
